XML 58 R5.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Millions
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Total revenue $ 442.0 $ 320.2 $ 293.8
Cost of sales 330.5 208.1 175.9
Gross profit (loss) 111.5 112.1 117.9
Advanced technology license and decommissioning costs 17.2 14.2 14.8
Selling, general and administrative 36.2 35.6 33.9
Amortization of intangible assets 9.8 6.3 9.0
Special charges for workforce reductions and advisory costs 0.3 3.6 0.5
Operating income (loss) 48.0 52.4 59.7
Nonoperating components of net periodic benefit expense (income) (14.7) (23.2) (6.6)
Interest expense 2.7 1.3 0.5
Investment income (12.9) (8.7) (2.0)
Other Nonoperating Income (0.1) (1.5) 0.0
Income (loss) before income taxes 73.0 84.5 67.8
Provision (benefit) for income taxes (0.2) 0.1 15.6
Net income (loss) 73.2 84.4 52.2
Distributed earnings allocable to warrant modification 0.0 0.0 1.5
Net income (loss) allocable to common stockholders $ 73.2 $ 84.4 $ 50.7
Net income (loss) per common share - basic $ 4.49 $ 5.55 $ 3.47
Net income (loss) per common share - diluted $ 4.47 $ 5.44 $ 3.38
Weighted-average number of shares outstanding:      
Average number of shares outstanding, basic 16,309 15,212 14,601
Average number of shares outstanding, diluted 16,373 15,501 14,988
Accumulated Deficit [Member]      
Net income (loss) $ 73.2 $ 84.4 $ 52.2
Distributed earnings allocable to warrant modification 0.0 0.0 1.5
Product [Member]      
Total revenue 349.9 269.0 235.6
Cost of sales 256.0 163.9 105.0
Separative Work Units [Member]      
Total revenue 246.8 208.2 196.2
Uranium [Member]      
Total revenue $ 103.1 $ 60.8 $ 39.4